thalidomide has been researched along with Antral Vascular Ectasia in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Santos, S | 1 |
| Bernardes, C | 1 |
| Borges, V | 1 |
| Ramos, G | 1 |
| Moser, S | 1 |
| Tischer, A | 1 |
| Karpi, A | 1 |
| Schleicher, M | 1 |
| Stavjanik, S | 1 |
| Gschwantler, M | 1 |
| Dunne, KA | 1 |
| Hill, J | 1 |
| Dillon, JF | 1 |
3 other studies available for thalidomide and Antral Vascular Ectasia
| Article | Year |
|---|---|
Gastric antral vascular ectasia (GAVE) and hereditary hemorrhagic telangiectasia (HHT): two different conditions, one treatment.
Topics: Angiogenesis Inhibitors; Argon Plasma Coagulation; Bevacizumab; Combined Modality Therapy; Erythrocy | 2020 |
Evidence that thalidomide is effective in recurrent bleeding from watermelon stomach associated with liver cirrhosis.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Female; Gastric Antral Vascular Ectasia; Gastrointestina | 2014 |
Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide.
Topics: Anemia, Refractory; Angiogenesis Inhibitors; Gastric Antral Vascular Ectasia; Humans; Male; Middle A | 2006 |